MedTrace Logo

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

NCT02551887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 647

Last updated 2016-03-11

Study results available
· View outcomes & findings →

Summary

Primary, Secondary, and Exploratory Objective(s):

Primary objective: To evaluate the effect of interventions on 1st dose uptake of HPV vaccine.

Conditions

  • Human Papilloma Virus Infection Type 11
  • Human Papilloma Virus Infection Type 16
  • Human Papilloma Virus Infection Type 18
  • Human Papilloma Virus Infection Type 6
  • Cervical Cancer
  • Genital Warts
  • Oropharyngeal Cancer

Interventions

BEHAVIORAL

Automated Reminder

Automated reminder shown to provider

BEHAVIORAL

Automated Reminder Plus Script

Provider sees both reminder and script.

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Indiana University

    collaborator OTHER

  • Regenstrief Institute, Inc.

    lead OTHER

Principal Investigators

  • Gregory D Zimet, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-04-30
Completion
2015-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02551887 on ClinicalTrials.gov